(Q45228135)

11 December 2017

title

Radiolabelling DOTA-peptides with 68Ga (English)

1 reference

11 December 2017

Wouter A P Breeman

1

1 reference

11 December 2017

Marion de Jong

2

1 reference

11 December 2017

Erik de Blois

3

1 reference

11 December 2017

Bert F Bernard

4

1 reference

11 December 2017

Mark Konijnenberg

5

1 reference

11 December 2017

Eric P Krenning

6

1 reference

11 December 2017

publication date

18 January 2005

1 reference

11 December 2017

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

11 December 2017

volume

32

1 reference

11 December 2017

issue

4

1 reference

11 December 2017

page(s)

478-485

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-004-1702-y

11 December 2017

exact match

0 references

cites work

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model

1 reference

12 December 2020

Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size.

1 reference

12 December 2020

DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy

1 reference

12 December 2020

A new generator for ionic gallium-68.

1 reference

12 December 2020

Review of 68Ga chemical and imaging studies at the MGH

1 reference

12 December 2020

In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man

1 reference

12 December 2020

Gallium-67 radiotoxicity in human U937 lymphoma cells

1 reference

12 December 2020

Emerging roles for radiometabolic therapy of tumors based on auger electron emission

1 reference

12 December 2020

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

1 reference

12 December 2020

The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions

1 reference

12 December 2020

Evaluation of Positron Emission Tomography Imaging Using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors

1 reference

12 December 2020

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy

1 reference

12 December 2020

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

12 December 2020

Availability of nuclear decay data in electronic form, including beta spectra not previously published

1 reference

12 December 2020

Synthesis and characterisation of [90Y]-Bz-DTPA-oct: a yttrium-90-labelled octreotide analogue for radiotherapy of somatostatin receptor-positive tumours

1 reference

12 December 2020

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

1 reference

12 December 2020

The chemistry of gallium and indium as related to radiopharmaceutical production

1 reference

12 December 2020

Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives

1 reference

12 December 2020

A review of radiopharmaceutical development with short-lived generator-produced radionuclides other than 99mTc

1 reference

12 December 2020

68Ga-labelled DOTA-derivatised peptide ligands

1 reference

12 December 2020

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group

1 reference

12 December 2020

Receptor targeting for tumor localisation and therapy with radiopeptides

1 reference

12 December 2020

Gallium radiopharmaceutical chemistry

1 reference

12 December 2020

Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities

1 reference

12 December 2020

PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas

1 reference

12 December 2020

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

12 December 2020

Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.

1 reference

12 December 2020

10.1007/S00259-004-1702-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1024759795

0 references

1 reference